ESiOR provides health-economic information in a form that supports decision-making. We design studies to evaluate, address and communicate the profitability and value associated with investment strategies concerning health-related technologies.
These products or technologies may be service processes, procedures, devices, pharmaceutical products, food or other products related to health or health-care.
Our health-economic information is directly beneficial in contexts such as drug pricing and reimbursement applications, formulary decisions of hospital-administered products, decisions to purchase devices or foodstuffs, as well as in value communication and when deciding on the organisation of health-care services.
For additional information, please contact us.